Trupanion
Valuation each multiple against its own 5-year range
Vs. peers Insurance - Property & Casualty
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Trupanion (TRUP) | 1.54B | 58.30 | 3.85 | 0.00% |
| Chubb Ltd (CB) | 141.99B | 13.03 | 1.94 | 1.07% |
| Progressive (PGR) | 133.67B | 11.66 | 3.88 | 6.01% |
| The Travelers Companies (TRV) | 82.02B | 10.34 | 2.78 | 1.20% |
| Allstate (ALL) | 66.07B | 6.06 | 2.18 | 1.59% |
| WR Berkley (WRB) | 29.09B | 16.56 | 3.03 | 0.49% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 46.5% below Morningstar's fair value estimate.
Fair value
Given the significant price pressure over the last year, Trupanion Inc might appear cheap. However, to account for the possibility that it may be a value trap, we've restricted its rating to 3 stars. The stock currently trades at a 34% discount to our quantitative fair value estimate of $52.09 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The firm's valuation metrics strengthen our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its enterprise value to EBITDA ratio of 7.5, which falls in the bottom 30% compared with global peers. Relative to the company's EBITDA, the enterprise value of the business is low, which contributes to our view that shares are undervalued.
The company's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's sales yield of 97.1%, for example, falls in the top 40% globally. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. This characteristic further promotes our favorable price/fair value ratio.
Economic moat
With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.
By Quantitative Equity Report
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Trupanion discussion 0 comments